Global Therapeutic Proteins and Oral Vaccines Market Research Report 2026(Status and Outlook)
Therapeutic proteins are engineered in the laboratory for pharmaceutical use. They include non-covalent binders, enzymes and albumin and therefore have a wide range of treatment applications. Oral vaccines are biologically prepared products, which provide active acquired immunity to diseases. There are currently oral vaccines targeting cholera, polio, rotavirus, smallpox and yellow fever, among others. Oral vaccines comprise an agent resembling the disease-causing microorganism, such as a live attenuated or killed viral particle or the micro-organisms toxins or surface proteins.The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Therapeutic Proteins and Oral Vaccines market size was estimated at USD 474.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.90% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Therapeutic Proteins and Oral Vaccines market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Therapeutic Proteins and Oral Vaccines market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Therapeutic Proteins and Oral Vaccines market.
Global Therapeutic Proteins and Oral Vaccines Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Abbott
Amgen
Biogen
Eli Lilly and Company
Roche
Johnson and Johnson
Merck
Novo Nordisk
Pfizer
Sanofi
Serum Institute of India
Emergent Biosolutions
TransAlgae
MigVax
Lumen Bioscience
Market Segmentation (by Type)
Therapeutic Proteins
Oral Vaccines
Market Segmentation (by Application)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Geographic Segmentation
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Therapeutic Proteins and Oral Vaccines Market
Overview of the regional outlook of the Therapeutic Proteins and Oral Vaccines Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Therapeutic Proteins and Oral Vaccines Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Therapeutic Proteins and Oral Vaccines, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Therapeutic Proteins and Oral Vaccines market size was estimated at USD 474.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.90% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Therapeutic Proteins and Oral Vaccines market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Therapeutic Proteins and Oral Vaccines market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Therapeutic Proteins and Oral Vaccines market.
Global Therapeutic Proteins and Oral Vaccines Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Abbott
Amgen
Biogen
Eli Lilly and Company
Roche
Johnson and Johnson
Merck
Novo Nordisk
Pfizer
Sanofi
Serum Institute of India
Emergent Biosolutions
TransAlgae
MigVax
Lumen Bioscience
Market Segmentation (by Type)
Therapeutic Proteins
Oral Vaccines
Market Segmentation (by Application)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Therapeutic Proteins and Oral Vaccines Market
Overview of the regional outlook of the Therapeutic Proteins and Oral Vaccines Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Therapeutic Proteins and Oral Vaccines Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Therapeutic Proteins and Oral Vaccines, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Therapeutic Proteins and Oral Vaccines
1.2 Key Market Segments
1.2.1 Therapeutic Proteins and Oral Vaccines Segment by Type
1.2.2 Therapeutic Proteins and Oral Vaccines Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 THERAPEUTIC PROTEINS AND ORAL VACCINES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Therapeutic Proteins and Oral Vaccines Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Therapeutic Proteins and Oral Vaccines Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 THERAPEUTIC PROTEINS AND ORAL VACCINES MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Therapeutic Proteins and Oral Vaccines Product Life Cycle
3.3 Global Therapeutic Proteins and Oral Vaccines Sales by Manufacturers (2020-2025)
3.4 Global Therapeutic Proteins and Oral Vaccines Revenue Market Share by Manufacturers (2020-2025)
3.5 Therapeutic Proteins and Oral Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Therapeutic Proteins and Oral Vaccines Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Therapeutic Proteins and Oral Vaccines Market Competitive Situation and Trends
3.8.1 Therapeutic Proteins and Oral Vaccines Market Concentration Rate
3.8.2 Global 5 and 10 Largest Therapeutic Proteins and Oral Vaccines Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 THERAPEUTIC PROTEINS AND ORAL VACCINES INDUSTRY CHAIN ANALYSIS
4.1 Therapeutic Proteins and Oral Vaccines Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF THERAPEUTIC PROTEINS AND ORAL VACCINES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Therapeutic Proteins and Oral Vaccines Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Therapeutic Proteins and Oral Vaccines Market
5.7 ESG Ratings of Leading Companies
6 THERAPEUTIC PROTEINS AND ORAL VACCINES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Therapeutic Proteins and Oral Vaccines Sales Market Share by Type (2020-2025)
6.3 Global Therapeutic Proteins and Oral Vaccines Market Size by Type (2020-2025)
6.4 Global Therapeutic Proteins and Oral Vaccines Price by Type (2020-2025)
7 THERAPEUTIC PROTEINS AND ORAL VACCINES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Therapeutic Proteins and Oral Vaccines Market Sales by Application (2020-2025)
7.3 Global Therapeutic Proteins and Oral Vaccines Market Size (M USD) by Application (2020-2025)
7.4 Global Therapeutic Proteins and Oral Vaccines Sales Growth Rate by Application (2020-2025)
8 THERAPEUTIC PROTEINS AND ORAL VACCINES MARKET SALES BY REGION
8.1 Global Therapeutic Proteins and Oral Vaccines Sales by Region
8.1.1 Global Therapeutic Proteins and Oral Vaccines Sales by Region
8.1.2 Global Therapeutic Proteins and Oral Vaccines Sales Market Share by Region
8.2 Global Therapeutic Proteins and Oral Vaccines Market Size by Region
8.2.1 Global Therapeutic Proteins and Oral Vaccines Market Size by Region
8.2.2 Global Therapeutic Proteins and Oral Vaccines Market Size by Region
8.3 North America
8.3.1 North America Therapeutic Proteins and Oral Vaccines Sales by Country
8.3.2 North America Therapeutic Proteins and Oral Vaccines Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Therapeutic Proteins and Oral Vaccines Sales by Country
8.4.2 Europe Therapeutic Proteins and Oral Vaccines Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Therapeutic Proteins and Oral Vaccines Sales by Region
8.5.2 Asia Pacific Therapeutic Proteins and Oral Vaccines Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Therapeutic Proteins and Oral Vaccines Sales by Country
8.6.2 South America Therapeutic Proteins and Oral Vaccines Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Therapeutic Proteins and Oral Vaccines Sales by Region
8.7.2 Middle East and Africa Therapeutic Proteins and Oral Vaccines Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 THERAPEUTIC PROTEINS AND ORAL VACCINES MARKET PRODUCTION BY REGION
9.1 Global Production of Therapeutic Proteins and Oral Vaccines by Region(2020-2025)
9.2 Global Therapeutic Proteins and Oral Vaccines Revenue Market Share by Region (2020-2025)
9.3 Global Therapeutic Proteins and Oral Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Therapeutic Proteins and Oral Vaccines Production
9.4.1 North America Therapeutic Proteins and Oral Vaccines Production Growth Rate (2020-2025)
9.4.2 North America Therapeutic Proteins and Oral Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Therapeutic Proteins and Oral Vaccines Production
9.5.1 Europe Therapeutic Proteins and Oral Vaccines Production Growth Rate (2020-2025)
9.5.2 Europe Therapeutic Proteins and Oral Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Therapeutic Proteins and Oral Vaccines Production (2020-2025)
9.6.1 Japan Therapeutic Proteins and Oral Vaccines Production Growth Rate (2020-2025)
9.6.2 Japan Therapeutic Proteins and Oral Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Therapeutic Proteins and Oral Vaccines Production (2020-2025)
9.7.1 China Therapeutic Proteins and Oral Vaccines Production Growth Rate (2020-2025)
9.7.2 China Therapeutic Proteins and Oral Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Abbott
10.1.1 Abbott Basic Information
10.1.2 Abbott Therapeutic Proteins and Oral Vaccines Product Overview
10.1.3 Abbott Therapeutic Proteins and Oral Vaccines Product Market Performance
10.1.4 Abbott Business Overview
10.1.5 Abbott SWOT Analysis
10.1.6 Abbott Recent Developments
10.2 Amgen
10.2.1 Amgen Basic Information
10.2.2 Amgen Therapeutic Proteins and Oral Vaccines Product Overview
10.2.3 Amgen Therapeutic Proteins and Oral Vaccines Product Market Performance
10.2.4 Amgen Business Overview
10.2.5 Amgen SWOT Analysis
10.2.6 Amgen Recent Developments
10.3 Biogen
10.3.1 Biogen Basic Information
10.3.2 Biogen Therapeutic Proteins and Oral Vaccines Product Overview
10.3.3 Biogen Therapeutic Proteins and Oral Vaccines Product Market Performance
10.3.4 Biogen Business Overview
10.3.5 Biogen SWOT Analysis
10.3.6 Biogen Recent Developments
10.4 Eli Lilly and Company
10.4.1 Eli Lilly and Company Basic Information
10.4.2 Eli Lilly and Company Therapeutic Proteins and Oral Vaccines Product Overview
10.4.3 Eli Lilly and Company Therapeutic Proteins and Oral Vaccines Product Market Performance
10.4.4 Eli Lilly and Company Business Overview
10.4.5 Eli Lilly and Company Recent Developments
10.5 Roche
10.5.1 Roche Basic Information
10.5.2 Roche Therapeutic Proteins and Oral Vaccines Product Overview
10.5.3 Roche Therapeutic Proteins and Oral Vaccines Product Market Performance
10.5.4 Roche Business Overview
10.5.5 Roche Recent Developments
10.6 Johnson and Johnson
10.6.1 Johnson and Johnson Basic Information
10.6.2 Johnson and Johnson Therapeutic Proteins and Oral Vaccines Product Overview
10.6.3 Johnson and Johnson Therapeutic Proteins and Oral Vaccines Product Market Performance
10.6.4 Johnson and Johnson Business Overview
10.6.5 Johnson and Johnson Recent Developments
10.7 Merck
10.7.1 Merck Basic Information
10.7.2 Merck Therapeutic Proteins and Oral Vaccines Product Overview
10.7.3 Merck Therapeutic Proteins and Oral Vaccines Product Market Performance
10.7.4 Merck Business Overview
10.7.5 Merck Recent Developments
10.8 Novo Nordisk
10.8.1 Novo Nordisk Basic Information
10.8.2 Novo Nordisk Therapeutic Proteins and Oral Vaccines Product Overview
10.8.3 Novo Nordisk Therapeutic Proteins and Oral Vaccines Product Market Performance
10.8.4 Novo Nordisk Business Overview
10.8.5 Novo Nordisk Recent Developments
10.9 Pfizer
10.9.1 Pfizer Basic Information
10.9.2 Pfizer Therapeutic Proteins and Oral Vaccines Product Overview
10.9.3 Pfizer Therapeutic Proteins and Oral Vaccines Product Market Performance
10.9.4 Pfizer Business Overview
10.9.5 Pfizer Recent Developments
10.10 Sanofi
10.10.1 Sanofi Basic Information
10.10.2 Sanofi Therapeutic Proteins and Oral Vaccines Product Overview
10.10.3 Sanofi Therapeutic Proteins and Oral Vaccines Product Market Performance
10.10.4 Sanofi Business Overview
10.10.5 Sanofi Recent Developments
10.11 Serum Institute of India
10.11.1 Serum Institute of India Basic Information
10.11.2 Serum Institute of India Therapeutic Proteins and Oral Vaccines Product Overview
10.11.3 Serum Institute of India Therapeutic Proteins and Oral Vaccines Product Market Performance
10.11.4 Serum Institute of India Business Overview
10.11.5 Serum Institute of India Recent Developments
10.12 Emergent Biosolutions
10.12.1 Emergent Biosolutions Basic Information
10.12.2 Emergent Biosolutions Therapeutic Proteins and Oral Vaccines Product Overview
10.12.3 Emergent Biosolutions Therapeutic Proteins and Oral Vaccines Product Market Performance
10.12.4 Emergent Biosolutions Business Overview
10.12.5 Emergent Biosolutions Recent Developments
10.13 TransAlgae
10.13.1 TransAlgae Basic Information
10.13.2 TransAlgae Therapeutic Proteins and Oral Vaccines Product Overview
10.13.3 TransAlgae Therapeutic Proteins and Oral Vaccines Product Market Performance
10.13.4 TransAlgae Business Overview
10.13.5 TransAlgae Recent Developments
10.14 MigVax
10.14.1 MigVax Basic Information
10.14.2 MigVax Therapeutic Proteins and Oral Vaccines Product Overview
10.14.3 MigVax Therapeutic Proteins and Oral Vaccines Product Market Performance
10.14.4 MigVax Business Overview
10.14.5 MigVax Recent Developments
10.15 Lumen Bioscience
10.15.1 Lumen Bioscience Basic Information
10.15.2 Lumen Bioscience Therapeutic Proteins and Oral Vaccines Product Overview
10.15.3 Lumen Bioscience Therapeutic Proteins and Oral Vaccines Product Market Performance
10.15.4 Lumen Bioscience Business Overview
10.15.5 Lumen Bioscience Recent Developments
11 THERAPEUTIC PROTEINS AND ORAL VACCINES MARKET FORECAST BY REGION
11.1 Global Therapeutic Proteins and Oral Vaccines Market Size Forecast
11.2 Global Therapeutic Proteins and Oral Vaccines Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Therapeutic Proteins and Oral Vaccines Market Size Forecast by Country
11.2.3 Asia Pacific Therapeutic Proteins and Oral Vaccines Market Size Forecast by Region
11.2.4 South America Therapeutic Proteins and Oral Vaccines Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Therapeutic Proteins and Oral Vaccines by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Therapeutic Proteins and Oral Vaccines Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Therapeutic Proteins and Oral Vaccines by Type (2026-2035)
12.1.2 Global Therapeutic Proteins and Oral Vaccines Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Therapeutic Proteins and Oral Vaccines by Type (2026-2035)
12.2 Global Therapeutic Proteins and Oral Vaccines Market Forecast by Application (2026-2035)
12.2.1 Global Therapeutic Proteins and Oral Vaccines Sales (K MT) Forecast by Application
12.2.2 Global Therapeutic Proteins and Oral Vaccines Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Therapeutic Proteins and Oral Vaccines
1.2 Key Market Segments
1.2.1 Therapeutic Proteins and Oral Vaccines Segment by Type
1.2.2 Therapeutic Proteins and Oral Vaccines Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 THERAPEUTIC PROTEINS AND ORAL VACCINES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Therapeutic Proteins and Oral Vaccines Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Therapeutic Proteins and Oral Vaccines Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 THERAPEUTIC PROTEINS AND ORAL VACCINES MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Therapeutic Proteins and Oral Vaccines Product Life Cycle
3.3 Global Therapeutic Proteins and Oral Vaccines Sales by Manufacturers (2020-2025)
3.4 Global Therapeutic Proteins and Oral Vaccines Revenue Market Share by Manufacturers (2020-2025)
3.5 Therapeutic Proteins and Oral Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Therapeutic Proteins and Oral Vaccines Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Therapeutic Proteins and Oral Vaccines Market Competitive Situation and Trends
3.8.1 Therapeutic Proteins and Oral Vaccines Market Concentration Rate
3.8.2 Global 5 and 10 Largest Therapeutic Proteins and Oral Vaccines Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 THERAPEUTIC PROTEINS AND ORAL VACCINES INDUSTRY CHAIN ANALYSIS
4.1 Therapeutic Proteins and Oral Vaccines Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF THERAPEUTIC PROTEINS AND ORAL VACCINES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Therapeutic Proteins and Oral Vaccines Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Therapeutic Proteins and Oral Vaccines Market
5.7 ESG Ratings of Leading Companies
6 THERAPEUTIC PROTEINS AND ORAL VACCINES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Therapeutic Proteins and Oral Vaccines Sales Market Share by Type (2020-2025)
6.3 Global Therapeutic Proteins and Oral Vaccines Market Size by Type (2020-2025)
6.4 Global Therapeutic Proteins and Oral Vaccines Price by Type (2020-2025)
7 THERAPEUTIC PROTEINS AND ORAL VACCINES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Therapeutic Proteins and Oral Vaccines Market Sales by Application (2020-2025)
7.3 Global Therapeutic Proteins and Oral Vaccines Market Size (M USD) by Application (2020-2025)
7.4 Global Therapeutic Proteins and Oral Vaccines Sales Growth Rate by Application (2020-2025)
8 THERAPEUTIC PROTEINS AND ORAL VACCINES MARKET SALES BY REGION
8.1 Global Therapeutic Proteins and Oral Vaccines Sales by Region
8.1.1 Global Therapeutic Proteins and Oral Vaccines Sales by Region
8.1.2 Global Therapeutic Proteins and Oral Vaccines Sales Market Share by Region
8.2 Global Therapeutic Proteins and Oral Vaccines Market Size by Region
8.2.1 Global Therapeutic Proteins and Oral Vaccines Market Size by Region
8.2.2 Global Therapeutic Proteins and Oral Vaccines Market Size by Region
8.3 North America
8.3.1 North America Therapeutic Proteins and Oral Vaccines Sales by Country
8.3.2 North America Therapeutic Proteins and Oral Vaccines Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Therapeutic Proteins and Oral Vaccines Sales by Country
8.4.2 Europe Therapeutic Proteins and Oral Vaccines Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Therapeutic Proteins and Oral Vaccines Sales by Region
8.5.2 Asia Pacific Therapeutic Proteins and Oral Vaccines Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Therapeutic Proteins and Oral Vaccines Sales by Country
8.6.2 South America Therapeutic Proteins and Oral Vaccines Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Therapeutic Proteins and Oral Vaccines Sales by Region
8.7.2 Middle East and Africa Therapeutic Proteins and Oral Vaccines Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 THERAPEUTIC PROTEINS AND ORAL VACCINES MARKET PRODUCTION BY REGION
9.1 Global Production of Therapeutic Proteins and Oral Vaccines by Region(2020-2025)
9.2 Global Therapeutic Proteins and Oral Vaccines Revenue Market Share by Region (2020-2025)
9.3 Global Therapeutic Proteins and Oral Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Therapeutic Proteins and Oral Vaccines Production
9.4.1 North America Therapeutic Proteins and Oral Vaccines Production Growth Rate (2020-2025)
9.4.2 North America Therapeutic Proteins and Oral Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Therapeutic Proteins and Oral Vaccines Production
9.5.1 Europe Therapeutic Proteins and Oral Vaccines Production Growth Rate (2020-2025)
9.5.2 Europe Therapeutic Proteins and Oral Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Therapeutic Proteins and Oral Vaccines Production (2020-2025)
9.6.1 Japan Therapeutic Proteins and Oral Vaccines Production Growth Rate (2020-2025)
9.6.2 Japan Therapeutic Proteins and Oral Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Therapeutic Proteins and Oral Vaccines Production (2020-2025)
9.7.1 China Therapeutic Proteins and Oral Vaccines Production Growth Rate (2020-2025)
9.7.2 China Therapeutic Proteins and Oral Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Abbott
10.1.1 Abbott Basic Information
10.1.2 Abbott Therapeutic Proteins and Oral Vaccines Product Overview
10.1.3 Abbott Therapeutic Proteins and Oral Vaccines Product Market Performance
10.1.4 Abbott Business Overview
10.1.5 Abbott SWOT Analysis
10.1.6 Abbott Recent Developments
10.2 Amgen
10.2.1 Amgen Basic Information
10.2.2 Amgen Therapeutic Proteins and Oral Vaccines Product Overview
10.2.3 Amgen Therapeutic Proteins and Oral Vaccines Product Market Performance
10.2.4 Amgen Business Overview
10.2.5 Amgen SWOT Analysis
10.2.6 Amgen Recent Developments
10.3 Biogen
10.3.1 Biogen Basic Information
10.3.2 Biogen Therapeutic Proteins and Oral Vaccines Product Overview
10.3.3 Biogen Therapeutic Proteins and Oral Vaccines Product Market Performance
10.3.4 Biogen Business Overview
10.3.5 Biogen SWOT Analysis
10.3.6 Biogen Recent Developments
10.4 Eli Lilly and Company
10.4.1 Eli Lilly and Company Basic Information
10.4.2 Eli Lilly and Company Therapeutic Proteins and Oral Vaccines Product Overview
10.4.3 Eli Lilly and Company Therapeutic Proteins and Oral Vaccines Product Market Performance
10.4.4 Eli Lilly and Company Business Overview
10.4.5 Eli Lilly and Company Recent Developments
10.5 Roche
10.5.1 Roche Basic Information
10.5.2 Roche Therapeutic Proteins and Oral Vaccines Product Overview
10.5.3 Roche Therapeutic Proteins and Oral Vaccines Product Market Performance
10.5.4 Roche Business Overview
10.5.5 Roche Recent Developments
10.6 Johnson and Johnson
10.6.1 Johnson and Johnson Basic Information
10.6.2 Johnson and Johnson Therapeutic Proteins and Oral Vaccines Product Overview
10.6.3 Johnson and Johnson Therapeutic Proteins and Oral Vaccines Product Market Performance
10.6.4 Johnson and Johnson Business Overview
10.6.5 Johnson and Johnson Recent Developments
10.7 Merck
10.7.1 Merck Basic Information
10.7.2 Merck Therapeutic Proteins and Oral Vaccines Product Overview
10.7.3 Merck Therapeutic Proteins and Oral Vaccines Product Market Performance
10.7.4 Merck Business Overview
10.7.5 Merck Recent Developments
10.8 Novo Nordisk
10.8.1 Novo Nordisk Basic Information
10.8.2 Novo Nordisk Therapeutic Proteins and Oral Vaccines Product Overview
10.8.3 Novo Nordisk Therapeutic Proteins and Oral Vaccines Product Market Performance
10.8.4 Novo Nordisk Business Overview
10.8.5 Novo Nordisk Recent Developments
10.9 Pfizer
10.9.1 Pfizer Basic Information
10.9.2 Pfizer Therapeutic Proteins and Oral Vaccines Product Overview
10.9.3 Pfizer Therapeutic Proteins and Oral Vaccines Product Market Performance
10.9.4 Pfizer Business Overview
10.9.5 Pfizer Recent Developments
10.10 Sanofi
10.10.1 Sanofi Basic Information
10.10.2 Sanofi Therapeutic Proteins and Oral Vaccines Product Overview
10.10.3 Sanofi Therapeutic Proteins and Oral Vaccines Product Market Performance
10.10.4 Sanofi Business Overview
10.10.5 Sanofi Recent Developments
10.11 Serum Institute of India
10.11.1 Serum Institute of India Basic Information
10.11.2 Serum Institute of India Therapeutic Proteins and Oral Vaccines Product Overview
10.11.3 Serum Institute of India Therapeutic Proteins and Oral Vaccines Product Market Performance
10.11.4 Serum Institute of India Business Overview
10.11.5 Serum Institute of India Recent Developments
10.12 Emergent Biosolutions
10.12.1 Emergent Biosolutions Basic Information
10.12.2 Emergent Biosolutions Therapeutic Proteins and Oral Vaccines Product Overview
10.12.3 Emergent Biosolutions Therapeutic Proteins and Oral Vaccines Product Market Performance
10.12.4 Emergent Biosolutions Business Overview
10.12.5 Emergent Biosolutions Recent Developments
10.13 TransAlgae
10.13.1 TransAlgae Basic Information
10.13.2 TransAlgae Therapeutic Proteins and Oral Vaccines Product Overview
10.13.3 TransAlgae Therapeutic Proteins and Oral Vaccines Product Market Performance
10.13.4 TransAlgae Business Overview
10.13.5 TransAlgae Recent Developments
10.14 MigVax
10.14.1 MigVax Basic Information
10.14.2 MigVax Therapeutic Proteins and Oral Vaccines Product Overview
10.14.3 MigVax Therapeutic Proteins and Oral Vaccines Product Market Performance
10.14.4 MigVax Business Overview
10.14.5 MigVax Recent Developments
10.15 Lumen Bioscience
10.15.1 Lumen Bioscience Basic Information
10.15.2 Lumen Bioscience Therapeutic Proteins and Oral Vaccines Product Overview
10.15.3 Lumen Bioscience Therapeutic Proteins and Oral Vaccines Product Market Performance
10.15.4 Lumen Bioscience Business Overview
10.15.5 Lumen Bioscience Recent Developments
11 THERAPEUTIC PROTEINS AND ORAL VACCINES MARKET FORECAST BY REGION
11.1 Global Therapeutic Proteins and Oral Vaccines Market Size Forecast
11.2 Global Therapeutic Proteins and Oral Vaccines Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Therapeutic Proteins and Oral Vaccines Market Size Forecast by Country
11.2.3 Asia Pacific Therapeutic Proteins and Oral Vaccines Market Size Forecast by Region
11.2.4 South America Therapeutic Proteins and Oral Vaccines Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Therapeutic Proteins and Oral Vaccines by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Therapeutic Proteins and Oral Vaccines Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Therapeutic Proteins and Oral Vaccines by Type (2026-2035)
12.1.2 Global Therapeutic Proteins and Oral Vaccines Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Therapeutic Proteins and Oral Vaccines by Type (2026-2035)
12.2 Global Therapeutic Proteins and Oral Vaccines Market Forecast by Application (2026-2035)
12.2.1 Global Therapeutic Proteins and Oral Vaccines Sales (K MT) Forecast by Application
12.2.2 Global Therapeutic Proteins and Oral Vaccines Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Therapeutic Proteins and Oral Vaccines Market Size by Type (M USD)
Table 4. Global Therapeutic Proteins and Oral Vaccines Market Size by Application
Table 5. Therapeutic Proteins and Oral Vaccines Market Size Comparison by Region (M USD)
Table 6. Global Therapeutic Proteins and Oral Vaccines Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Therapeutic Proteins and Oral Vaccines Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Therapeutic Proteins and Oral Vaccines Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Therapeutic Proteins and Oral Vaccines Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Proteins and Oral Vaccines as of 2025)
Table 11. Global Market Therapeutic Proteins and Oral Vaccines Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Therapeutic Proteins and Oral Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Therapeutic Proteins and Oral Vaccines Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Therapeutic Proteins and Oral Vaccines Sales by Type (K MT)
Table 27. Global Therapeutic Proteins and Oral Vaccines Market Size by Type (M USD)
Table 28. Global Therapeutic Proteins and Oral Vaccines Sales (K MT) by Type (2020-2025)
Table 29. Global Therapeutic Proteins and Oral Vaccines Sales Market Share by Type (2020-2025)
Table 30. Global Therapeutic Proteins and Oral Vaccines Market Size (M USD) by Type (2020-2025)
Table 31. Global Therapeutic Proteins and Oral Vaccines Market Share by Type (2020-2025)
Table 32. Global Therapeutic Proteins and Oral Vaccines Price (USD/KG) by Type (2020-2025)
Table 33. Global Therapeutic Proteins and Oral Vaccines Sales (K MT) by Application
Table 34. Global Therapeutic Proteins and Oral Vaccines Market Size by Application
Table 35. Global Therapeutic Proteins and Oral Vaccines Sales by Application (2020-2025) & (K MT)
Table 36. Global Therapeutic Proteins and Oral Vaccines Sales Market Share by Application (2020-2025)
Table 37. Global Therapeutic Proteins and Oral Vaccines Market Size by Application (2020-2025) & (M USD)
Table 38. Global Therapeutic Proteins and Oral Vaccines Market Share by Application (2020-2025)
Table 39. Global Therapeutic Proteins and Oral Vaccines Sales Growth Rate by Application (2020-2025)
Table 40. Global Therapeutic Proteins and Oral Vaccines Sales by Region (2020-2025) & (K MT)
Table 41. Global Therapeutic Proteins and Oral Vaccines Sales Market Share by Region (2020-2025)
Table 42. Global Therapeutic Proteins and Oral Vaccines Market Size by Region (2020-2025) & (M USD)
Table 43. Global Therapeutic Proteins and Oral Vaccines Market Size by Region (2020-2025)
Table 44. North America Therapeutic Proteins and Oral Vaccines Sales by Country (2020-2025) & (K MT)
Table 45. North America Therapeutic Proteins and Oral Vaccines Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Therapeutic Proteins and Oral Vaccines Sales by Country (2020-2025) & (K MT)
Table 47. Europe Therapeutic Proteins and Oral Vaccines Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Therapeutic Proteins and Oral Vaccines Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Therapeutic Proteins and Oral Vaccines Market Size by Region (2020-2025) & (M USD)
Table 50. South America Therapeutic Proteins and Oral Vaccines Sales by Country (2020-2025) & (K MT)
Table 51. South America Therapeutic Proteins and Oral Vaccines Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Therapeutic Proteins and Oral Vaccines Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Therapeutic Proteins and Oral Vaccines Market Size by Region (2020-2025) & (M USD)
Table 54. Global Therapeutic Proteins and Oral Vaccines Production (K MT) by Region(2020-2025)
Table 55. Global Therapeutic Proteins and Oral Vaccines Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Therapeutic Proteins and Oral Vaccines Revenue Market Share by Region (2020-2025)
Table 57. Global Therapeutic Proteins and Oral Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Therapeutic Proteins and Oral Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Therapeutic Proteins and Oral Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Therapeutic Proteins and Oral Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Therapeutic Proteins and Oral Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Abbott Basic Information
Table 63. Abbott Therapeutic Proteins and Oral Vaccines Product Overview
Table 64. Abbott Therapeutic Proteins and Oral Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Abbott Business Overview
Table 66. Abbott SWOT Analysis
Table 67. Abbott Recent Developments
Table 68. Amgen Basic Information
Table 69. Amgen Therapeutic Proteins and Oral Vaccines Product Overview
Table 70. Amgen Therapeutic Proteins and Oral Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Amgen Business Overview
Table 72. Amgen SWOT Analysis
Table 73. Amgen Recent Developments
Table 74. Biogen Basic Information
Table 75. Biogen Therapeutic Proteins and Oral Vaccines Product Overview
Table 76. Biogen Therapeutic Proteins and Oral Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Biogen Business Overview
Table 78. Biogen SWOT Analysis
Table 79. Biogen Recent Developments
Table 80. Eli Lilly and Company Basic Information
Table 81. Eli Lilly and Company Therapeutic Proteins and Oral Vaccines Product Overview
Table 82. Eli Lilly and Company Therapeutic Proteins and Oral Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Eli Lilly and Company Business Overview
Table 84. Eli Lilly and Company Recent Developments
Table 85. Roche Basic Information
Table 86. Roche Therapeutic Proteins and Oral Vaccines Product Overview
Table 87. Roche Therapeutic Proteins and Oral Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Roche Business Overview
Table 89. Roche Recent Developments
Table 90. Johnson and Johnson Basic Information
Table 91. Johnson and Johnson Therapeutic Proteins and Oral Vaccines Product Overview
Table 92. Johnson and Johnson Therapeutic Proteins and Oral Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Johnson and Johnson Business Overview
Table 94. Johnson and Johnson Recent Developments
Table 95. Merck Basic Information
Table 96. Merck Therapeutic Proteins and Oral Vaccines Product Overview
Table 97. Merck Therapeutic Proteins and Oral Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Merck Business Overview
Table 99. Merck Recent Developments
Table 100. Novo Nordisk Basic Information
Table 101. Novo Nordisk Therapeutic Proteins and Oral Vaccines Product Overview
Table 102. Novo Nordisk Therapeutic Proteins and Oral Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Novo Nordisk Business Overview
Table 104. Novo Nordisk Recent Developments
Table 105. Pfizer Basic Information
Table 106. Pfizer Therapeutic Proteins and Oral Vaccines Product Overview
Table 107. Pfizer Therapeutic Proteins and Oral Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Pfizer Business Overview
Table 109. Pfizer Recent Developments
Table 110. Sanofi Basic Information
Table 111. Sanofi Therapeutic Proteins and Oral Vaccines Product Overview
Table 112. Sanofi Therapeutic Proteins and Oral Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Sanofi Business Overview
Table 114. Sanofi Recent Developments
Table 115. Serum Institute of India Basic Information
Table 116. Serum Institute of India Therapeutic Proteins and Oral Vaccines Product Overview
Table 117. Serum Institute of India Therapeutic Proteins and Oral Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Serum Institute of India Business Overview
Table 119. Serum Institute of India Recent Developments
Table 120. Emergent Biosolutions Basic Information
Table 121. Emergent Biosolutions Therapeutic Proteins and Oral Vaccines Product Overview
Table 122. Emergent Biosolutions Therapeutic Proteins and Oral Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Emergent Biosolutions Business Overview
Table 124. Emergent Biosolutions Recent Developments
Table 125. TransAlgae Basic Information
Table 126. TransAlgae Therapeutic Proteins and Oral Vaccines Product Overview
Table 127. TransAlgae Therapeutic Proteins and Oral Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. TransAlgae Business Overview
Table 129. TransAlgae Recent Developments
Table 130. MigVax Basic Information
Table 131. MigVax Therapeutic Proteins and Oral Vaccines Product Overview
Table 132. MigVax Therapeutic Proteins and Oral Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. MigVax Business Overview
Table 134. MigVax Recent Developments
Table 135. Lumen Bioscience Basic Information
Table 136. Lumen Bioscience Therapeutic Proteins and Oral Vaccines Product Overview
Table 137. Lumen Bioscience Therapeutic Proteins and Oral Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Lumen Bioscience Business Overview
Table 139. Lumen Bioscience Recent Developments
Table 140. Global Therapeutic Proteins and Oral Vaccines Sales Forecast by Region (2026-2035) & (K MT)
Table 141. Global Therapeutic Proteins and Oral Vaccines Market Size Forecast by Region (2026-2035) & (M USD)
Table 142. North America Therapeutic Proteins and Oral Vaccines Sales Forecast by Country (2026-2035) & (K MT)
Table 143. North America Therapeutic Proteins and Oral Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 144. Europe Therapeutic Proteins and Oral Vaccines Sales Forecast by Country (2026-2035) & (K MT)
Table 145. Europe Therapeutic Proteins and Oral Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 146. Asia Pacific Therapeutic Proteins and Oral Vaccines Sales Forecast by Region (2026-2035) & (K MT)
Table 147. Asia Pacific Therapeutic Proteins and Oral Vaccines Market Size Forecast by Region (2026-2035) & (M USD)
Table 148. South America Therapeutic Proteins and Oral Vaccines Sales Forecast by Country (2026-2035) & (K MT)
Table 149. South America Therapeutic Proteins and Oral Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 150. Middle East and Africa Therapeutic Proteins and Oral Vaccines Sales Forecast by Country (2026-2035) & (Units)
Table 151. Middle East and Africa Therapeutic Proteins and Oral Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 152. Global Therapeutic Proteins and Oral Vaccines Sales Forecast by Type (2026-2035) & (K MT)
Table 153. Global Therapeutic Proteins and Oral Vaccines Market Size Forecast by Type (2026-2035) & (M USD)
Table 154. Global Therapeutic Proteins and Oral Vaccines Price Forecast by Type (2026-2035) & (USD/KG)
Table 155. Global Therapeutic Proteins and Oral Vaccines Sales (K MT) Forecast by Application (2026-2035)
Table 156. Global Therapeutic Proteins and Oral Vaccines Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Therapeutic Proteins and Oral Vaccines Market Size by Type (M USD)
Table 4. Global Therapeutic Proteins and Oral Vaccines Market Size by Application
Table 5. Therapeutic Proteins and Oral Vaccines Market Size Comparison by Region (M USD)
Table 6. Global Therapeutic Proteins and Oral Vaccines Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Therapeutic Proteins and Oral Vaccines Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Therapeutic Proteins and Oral Vaccines Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Therapeutic Proteins and Oral Vaccines Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Proteins and Oral Vaccines as of 2025)
Table 11. Global Market Therapeutic Proteins and Oral Vaccines Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Therapeutic Proteins and Oral Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Therapeutic Proteins and Oral Vaccines Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Therapeutic Proteins and Oral Vaccines Sales by Type (K MT)
Table 27. Global Therapeutic Proteins and Oral Vaccines Market Size by Type (M USD)
Table 28. Global Therapeutic Proteins and Oral Vaccines Sales (K MT) by Type (2020-2025)
Table 29. Global Therapeutic Proteins and Oral Vaccines Sales Market Share by Type (2020-2025)
Table 30. Global Therapeutic Proteins and Oral Vaccines Market Size (M USD) by Type (2020-2025)
Table 31. Global Therapeutic Proteins and Oral Vaccines Market Share by Type (2020-2025)
Table 32. Global Therapeutic Proteins and Oral Vaccines Price (USD/KG) by Type (2020-2025)
Table 33. Global Therapeutic Proteins and Oral Vaccines Sales (K MT) by Application
Table 34. Global Therapeutic Proteins and Oral Vaccines Market Size by Application
Table 35. Global Therapeutic Proteins and Oral Vaccines Sales by Application (2020-2025) & (K MT)
Table 36. Global Therapeutic Proteins and Oral Vaccines Sales Market Share by Application (2020-2025)
Table 37. Global Therapeutic Proteins and Oral Vaccines Market Size by Application (2020-2025) & (M USD)
Table 38. Global Therapeutic Proteins and Oral Vaccines Market Share by Application (2020-2025)
Table 39. Global Therapeutic Proteins and Oral Vaccines Sales Growth Rate by Application (2020-2025)
Table 40. Global Therapeutic Proteins and Oral Vaccines Sales by Region (2020-2025) & (K MT)
Table 41. Global Therapeutic Proteins and Oral Vaccines Sales Market Share by Region (2020-2025)
Table 42. Global Therapeutic Proteins and Oral Vaccines Market Size by Region (2020-2025) & (M USD)
Table 43. Global Therapeutic Proteins and Oral Vaccines Market Size by Region (2020-2025)
Table 44. North America Therapeutic Proteins and Oral Vaccines Sales by Country (2020-2025) & (K MT)
Table 45. North America Therapeutic Proteins and Oral Vaccines Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Therapeutic Proteins and Oral Vaccines Sales by Country (2020-2025) & (K MT)
Table 47. Europe Therapeutic Proteins and Oral Vaccines Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Therapeutic Proteins and Oral Vaccines Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Therapeutic Proteins and Oral Vaccines Market Size by Region (2020-2025) & (M USD)
Table 50. South America Therapeutic Proteins and Oral Vaccines Sales by Country (2020-2025) & (K MT)
Table 51. South America Therapeutic Proteins and Oral Vaccines Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Therapeutic Proteins and Oral Vaccines Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Therapeutic Proteins and Oral Vaccines Market Size by Region (2020-2025) & (M USD)
Table 54. Global Therapeutic Proteins and Oral Vaccines Production (K MT) by Region(2020-2025)
Table 55. Global Therapeutic Proteins and Oral Vaccines Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Therapeutic Proteins and Oral Vaccines Revenue Market Share by Region (2020-2025)
Table 57. Global Therapeutic Proteins and Oral Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Therapeutic Proteins and Oral Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Therapeutic Proteins and Oral Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Therapeutic Proteins and Oral Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Therapeutic Proteins and Oral Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Abbott Basic Information
Table 63. Abbott Therapeutic Proteins and Oral Vaccines Product Overview
Table 64. Abbott Therapeutic Proteins and Oral Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Abbott Business Overview
Table 66. Abbott SWOT Analysis
Table 67. Abbott Recent Developments
Table 68. Amgen Basic Information
Table 69. Amgen Therapeutic Proteins and Oral Vaccines Product Overview
Table 70. Amgen Therapeutic Proteins and Oral Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Amgen Business Overview
Table 72. Amgen SWOT Analysis
Table 73. Amgen Recent Developments
Table 74. Biogen Basic Information
Table 75. Biogen Therapeutic Proteins and Oral Vaccines Product Overview
Table 76. Biogen Therapeutic Proteins and Oral Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Biogen Business Overview
Table 78. Biogen SWOT Analysis
Table 79. Biogen Recent Developments
Table 80. Eli Lilly and Company Basic Information
Table 81. Eli Lilly and Company Therapeutic Proteins and Oral Vaccines Product Overview
Table 82. Eli Lilly and Company Therapeutic Proteins and Oral Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Eli Lilly and Company Business Overview
Table 84. Eli Lilly and Company Recent Developments
Table 85. Roche Basic Information
Table 86. Roche Therapeutic Proteins and Oral Vaccines Product Overview
Table 87. Roche Therapeutic Proteins and Oral Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Roche Business Overview
Table 89. Roche Recent Developments
Table 90. Johnson and Johnson Basic Information
Table 91. Johnson and Johnson Therapeutic Proteins and Oral Vaccines Product Overview
Table 92. Johnson and Johnson Therapeutic Proteins and Oral Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Johnson and Johnson Business Overview
Table 94. Johnson and Johnson Recent Developments
Table 95. Merck Basic Information
Table 96. Merck Therapeutic Proteins and Oral Vaccines Product Overview
Table 97. Merck Therapeutic Proteins and Oral Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Merck Business Overview
Table 99. Merck Recent Developments
Table 100. Novo Nordisk Basic Information
Table 101. Novo Nordisk Therapeutic Proteins and Oral Vaccines Product Overview
Table 102. Novo Nordisk Therapeutic Proteins and Oral Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Novo Nordisk Business Overview
Table 104. Novo Nordisk Recent Developments
Table 105. Pfizer Basic Information
Table 106. Pfizer Therapeutic Proteins and Oral Vaccines Product Overview
Table 107. Pfizer Therapeutic Proteins and Oral Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Pfizer Business Overview
Table 109. Pfizer Recent Developments
Table 110. Sanofi Basic Information
Table 111. Sanofi Therapeutic Proteins and Oral Vaccines Product Overview
Table 112. Sanofi Therapeutic Proteins and Oral Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Sanofi Business Overview
Table 114. Sanofi Recent Developments
Table 115. Serum Institute of India Basic Information
Table 116. Serum Institute of India Therapeutic Proteins and Oral Vaccines Product Overview
Table 117. Serum Institute of India Therapeutic Proteins and Oral Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Serum Institute of India Business Overview
Table 119. Serum Institute of India Recent Developments
Table 120. Emergent Biosolutions Basic Information
Table 121. Emergent Biosolutions Therapeutic Proteins and Oral Vaccines Product Overview
Table 122. Emergent Biosolutions Therapeutic Proteins and Oral Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Emergent Biosolutions Business Overview
Table 124. Emergent Biosolutions Recent Developments
Table 125. TransAlgae Basic Information
Table 126. TransAlgae Therapeutic Proteins and Oral Vaccines Product Overview
Table 127. TransAlgae Therapeutic Proteins and Oral Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. TransAlgae Business Overview
Table 129. TransAlgae Recent Developments
Table 130. MigVax Basic Information
Table 131. MigVax Therapeutic Proteins and Oral Vaccines Product Overview
Table 132. MigVax Therapeutic Proteins and Oral Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. MigVax Business Overview
Table 134. MigVax Recent Developments
Table 135. Lumen Bioscience Basic Information
Table 136. Lumen Bioscience Therapeutic Proteins and Oral Vaccines Product Overview
Table 137. Lumen Bioscience Therapeutic Proteins and Oral Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Lumen Bioscience Business Overview
Table 139. Lumen Bioscience Recent Developments
Table 140. Global Therapeutic Proteins and Oral Vaccines Sales Forecast by Region (2026-2035) & (K MT)
Table 141. Global Therapeutic Proteins and Oral Vaccines Market Size Forecast by Region (2026-2035) & (M USD)
Table 142. North America Therapeutic Proteins and Oral Vaccines Sales Forecast by Country (2026-2035) & (K MT)
Table 143. North America Therapeutic Proteins and Oral Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 144. Europe Therapeutic Proteins and Oral Vaccines Sales Forecast by Country (2026-2035) & (K MT)
Table 145. Europe Therapeutic Proteins and Oral Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 146. Asia Pacific Therapeutic Proteins and Oral Vaccines Sales Forecast by Region (2026-2035) & (K MT)
Table 147. Asia Pacific Therapeutic Proteins and Oral Vaccines Market Size Forecast by Region (2026-2035) & (M USD)
Table 148. South America Therapeutic Proteins and Oral Vaccines Sales Forecast by Country (2026-2035) & (K MT)
Table 149. South America Therapeutic Proteins and Oral Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 150. Middle East and Africa Therapeutic Proteins and Oral Vaccines Sales Forecast by Country (2026-2035) & (Units)
Table 151. Middle East and Africa Therapeutic Proteins and Oral Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 152. Global Therapeutic Proteins and Oral Vaccines Sales Forecast by Type (2026-2035) & (K MT)
Table 153. Global Therapeutic Proteins and Oral Vaccines Market Size Forecast by Type (2026-2035) & (M USD)
Table 154. Global Therapeutic Proteins and Oral Vaccines Price Forecast by Type (2026-2035) & (USD/KG)
Table 155. Global Therapeutic Proteins and Oral Vaccines Sales (K MT) Forecast by Application (2026-2035)
Table 156. Global Therapeutic Proteins and Oral Vaccines Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Therapeutic Proteins and Oral Vaccines
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Therapeutic Proteins and Oral Vaccines Market Size (M USD), 2025-2035
Figure 5. Global Therapeutic Proteins and Oral Vaccines Market Size (M USD) (2020-2035)
Figure 6. Global Therapeutic Proteins and Oral Vaccines Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Therapeutic Proteins and Oral Vaccines Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Therapeutic Proteins and Oral Vaccines Product Life Cycle
Figure 13. Therapeutic Proteins and Oral Vaccines Sales Share by Manufacturers in 2025
Figure 14. Global Therapeutic Proteins and Oral Vaccines Revenue Share by Manufacturers in 2025
Figure 15. Therapeutic Proteins and Oral Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Therapeutic Proteins and Oral Vaccines Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Therapeutic Proteins and Oral Vaccines Revenue in 2025
Figure 18. Industry Chain Map of Therapeutic Proteins and Oral Vaccines
Figure 19. Global Therapeutic Proteins and Oral Vaccines Market PEST Analysis
Figure 20. Global Therapeutic Proteins and Oral Vaccines Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Therapeutic Proteins and Oral Vaccines Market Share by Type
Figure 27. Sales Market Share of Therapeutic Proteins and Oral Vaccines by Type (2020-2025)
Figure 28. Sales Market Share of Therapeutic Proteins and Oral Vaccines by Type in 2025
Figure 29. Market Share of Therapeutic Proteins and Oral Vaccines by Type (2020-2025)
Figure 30. Market Share of Therapeutic Proteins and Oral Vaccines by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Therapeutic Proteins and Oral Vaccines Market Share by Application
Figure 33. Global Therapeutic Proteins and Oral Vaccines Sales Market Share by Application (2020-2025)
Figure 34. Global Therapeutic Proteins and Oral Vaccines Sales Market Share by Application in 2025
Figure 35. Global Therapeutic Proteins and Oral Vaccines Market Share by Application (2020-2025)
Figure 36. Global Therapeutic Proteins and Oral Vaccines Market Share by Application in 2025
Figure 37. Global Therapeutic Proteins and Oral Vaccines Sales Growth Rate by Application (2020-2025)
Figure 38. Global Therapeutic Proteins and Oral Vaccines Sales Market Share by Region (2020-2025)
Figure 39. Global Therapeutic Proteins and Oral Vaccines Market Size by Region (2020-2025)
Figure 40. North America Therapeutic Proteins and Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Therapeutic Proteins and Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Therapeutic Proteins and Oral Vaccines Sales Market Share by Country in 2024
Figure 43. North America Therapeutic Proteins and Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Therapeutic Proteins and Oral Vaccines Market Size by Country in 2024
Figure 45. U.S. Therapeutic Proteins and Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Therapeutic Proteins and Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Therapeutic Proteins and Oral Vaccines Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Therapeutic Proteins and Oral Vaccines Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Therapeutic Proteins and Oral Vaccines Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Therapeutic Proteins and Oral Vaccines Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Therapeutic Proteins and Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Therapeutic Proteins and Oral Vaccines Sales Market Share by Country in 2024
Figure 53. Europe Therapeutic Proteins and Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Therapeutic Proteins and Oral Vaccines Market Size by Country in 2024
Figure 55. Germany Therapeutic Proteins and Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Therapeutic Proteins and Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Therapeutic Proteins and Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Therapeutic Proteins and Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Therapeutic Proteins and Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Therapeutic Proteins and Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Therapeutic Proteins and Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Therapeutic Proteins and Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Therapeutic Proteins and Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Therapeutic Proteins and Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Therapeutic Proteins and Oral Vaccines Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Therapeutic Proteins and Oral Vaccines Sales Market Share by Region in 2024
Figure 67. Asia Pacific Therapeutic Proteins and Oral Vaccines Market Size by Region in 2024
Figure 68. China Therapeutic Proteins and Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Therapeutic Proteins and Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Therapeutic Proteins and Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Therapeutic Proteins and Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Therapeutic Proteins and Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Therapeutic Proteins and Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Therapeutic Proteins and Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Therapeutic Proteins and Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Therapeutic Proteins and Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Therapeutic Proteins and Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Therapeutic Proteins and Oral Vaccines Sales and Growth Rate (K MT)
Figure 79. South America Therapeutic Proteins and Oral Vaccines Sales Market Share by Country in 2024
Figure 80. South America Therapeutic Proteins and Oral Vaccines Market Size and Growth Rate (M USD)
Figure 81. South America Therapeutic Proteins and Oral Vaccines Market Size by Country in 2024
Figure 82. Brazil Therapeutic Proteins and Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Therapeutic Proteins and Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Therapeutic Proteins and Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Therapeutic Proteins and Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Therapeutic Proteins and Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Therapeutic Proteins and Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Therapeutic Proteins and Oral Vaccines Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Therapeutic Proteins and Oral Vaccines Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Therapeutic Proteins and Oral Vaccines Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Therapeutic Proteins and Oral Vaccines Market Size by Region in 2024
Figure 92. Saudi Arabia Therapeutic Proteins and Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Therapeutic Proteins and Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Therapeutic Proteins and Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Therapeutic Proteins and Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Therapeutic Proteins and Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Therapeutic Proteins and Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Therapeutic Proteins and Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Therapeutic Proteins and Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Therapeutic Proteins and Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Therapeutic Proteins and Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Therapeutic Proteins and Oral Vaccines Production Market Share by Region (2020-2025)
Figure 103. North America Therapeutic Proteins and Oral Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Therapeutic Proteins and Oral Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Therapeutic Proteins and Oral Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 106. China Therapeutic Proteins and Oral Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Therapeutic Proteins and Oral Vaccines Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Therapeutic Proteins and Oral Vaccines Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Therapeutic Proteins and Oral Vaccines Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Therapeutic Proteins and Oral Vaccines Market Share Forecast by Type (2026-2035)
Figure 111. Global Therapeutic Proteins and Oral Vaccines Sales Forecast by Application (2026-2035)
Figure 112. Global Therapeutic Proteins and Oral Vaccines Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Therapeutic Proteins and Oral Vaccines
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Therapeutic Proteins and Oral Vaccines Market Size (M USD), 2025-2035
Figure 5. Global Therapeutic Proteins and Oral Vaccines Market Size (M USD) (2020-2035)
Figure 6. Global Therapeutic Proteins and Oral Vaccines Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Therapeutic Proteins and Oral Vaccines Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Therapeutic Proteins and Oral Vaccines Product Life Cycle
Figure 13. Therapeutic Proteins and Oral Vaccines Sales Share by Manufacturers in 2025
Figure 14. Global Therapeutic Proteins and Oral Vaccines Revenue Share by Manufacturers in 2025
Figure 15. Therapeutic Proteins and Oral Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Therapeutic Proteins and Oral Vaccines Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Therapeutic Proteins and Oral Vaccines Revenue in 2025
Figure 18. Industry Chain Map of Therapeutic Proteins and Oral Vaccines
Figure 19. Global Therapeutic Proteins and Oral Vaccines Market PEST Analysis
Figure 20. Global Therapeutic Proteins and Oral Vaccines Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Therapeutic Proteins and Oral Vaccines Market Share by Type
Figure 27. Sales Market Share of Therapeutic Proteins and Oral Vaccines by Type (2020-2025)
Figure 28. Sales Market Share of Therapeutic Proteins and Oral Vaccines by Type in 2025
Figure 29. Market Share of Therapeutic Proteins and Oral Vaccines by Type (2020-2025)
Figure 30. Market Share of Therapeutic Proteins and Oral Vaccines by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Therapeutic Proteins and Oral Vaccines Market Share by Application
Figure 33. Global Therapeutic Proteins and Oral Vaccines Sales Market Share by Application (2020-2025)
Figure 34. Global Therapeutic Proteins and Oral Vaccines Sales Market Share by Application in 2025
Figure 35. Global Therapeutic Proteins and Oral Vaccines Market Share by Application (2020-2025)
Figure 36. Global Therapeutic Proteins and Oral Vaccines Market Share by Application in 2025
Figure 37. Global Therapeutic Proteins and Oral Vaccines Sales Growth Rate by Application (2020-2025)
Figure 38. Global Therapeutic Proteins and Oral Vaccines Sales Market Share by Region (2020-2025)
Figure 39. Global Therapeutic Proteins and Oral Vaccines Market Size by Region (2020-2025)
Figure 40. North America Therapeutic Proteins and Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Therapeutic Proteins and Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Therapeutic Proteins and Oral Vaccines Sales Market Share by Country in 2024
Figure 43. North America Therapeutic Proteins and Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Therapeutic Proteins and Oral Vaccines Market Size by Country in 2024
Figure 45. U.S. Therapeutic Proteins and Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Therapeutic Proteins and Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Therapeutic Proteins and Oral Vaccines Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Therapeutic Proteins and Oral Vaccines Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Therapeutic Proteins and Oral Vaccines Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Therapeutic Proteins and Oral Vaccines Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Therapeutic Proteins and Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Therapeutic Proteins and Oral Vaccines Sales Market Share by Country in 2024
Figure 53. Europe Therapeutic Proteins and Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Therapeutic Proteins and Oral Vaccines Market Size by Country in 2024
Figure 55. Germany Therapeutic Proteins and Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Therapeutic Proteins and Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Therapeutic Proteins and Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Therapeutic Proteins and Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Therapeutic Proteins and Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Therapeutic Proteins and Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Therapeutic Proteins and Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Therapeutic Proteins and Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Therapeutic Proteins and Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Therapeutic Proteins and Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Therapeutic Proteins and Oral Vaccines Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Therapeutic Proteins and Oral Vaccines Sales Market Share by Region in 2024
Figure 67. Asia Pacific Therapeutic Proteins and Oral Vaccines Market Size by Region in 2024
Figure 68. China Therapeutic Proteins and Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Therapeutic Proteins and Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Therapeutic Proteins and Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Therapeutic Proteins and Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Therapeutic Proteins and Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Therapeutic Proteins and Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Therapeutic Proteins and Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Therapeutic Proteins and Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Therapeutic Proteins and Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Therapeutic Proteins and Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Therapeutic Proteins and Oral Vaccines Sales and Growth Rate (K MT)
Figure 79. South America Therapeutic Proteins and Oral Vaccines Sales Market Share by Country in 2024
Figure 80. South America Therapeutic Proteins and Oral Vaccines Market Size and Growth Rate (M USD)
Figure 81. South America Therapeutic Proteins and Oral Vaccines Market Size by Country in 2024
Figure 82. Brazil Therapeutic Proteins and Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Therapeutic Proteins and Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Therapeutic Proteins and Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Therapeutic Proteins and Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Therapeutic Proteins and Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Therapeutic Proteins and Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Therapeutic Proteins and Oral Vaccines Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Therapeutic Proteins and Oral Vaccines Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Therapeutic Proteins and Oral Vaccines Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Therapeutic Proteins and Oral Vaccines Market Size by Region in 2024
Figure 92. Saudi Arabia Therapeutic Proteins and Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Therapeutic Proteins and Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Therapeutic Proteins and Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Therapeutic Proteins and Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Therapeutic Proteins and Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Therapeutic Proteins and Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Therapeutic Proteins and Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Therapeutic Proteins and Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Therapeutic Proteins and Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Therapeutic Proteins and Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Therapeutic Proteins and Oral Vaccines Production Market Share by Region (2020-2025)
Figure 103. North America Therapeutic Proteins and Oral Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Therapeutic Proteins and Oral Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Therapeutic Proteins and Oral Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 106. China Therapeutic Proteins and Oral Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Therapeutic Proteins and Oral Vaccines Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Therapeutic Proteins and Oral Vaccines Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Therapeutic Proteins and Oral Vaccines Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Therapeutic Proteins and Oral Vaccines Market Share Forecast by Type (2026-2035)
Figure 111. Global Therapeutic Proteins and Oral Vaccines Sales Forecast by Application (2026-2035)
Figure 112. Global Therapeutic Proteins and Oral Vaccines Market Share Forecast by Application (2026-2035)
